Related Experiment Video
Updated: Jan 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Invasive infections by non-vaccine serotypes of Streptococcus pneumoniae: a growing threat
Lorena Rodríguez-Muñoz1, Fortino Solórzano-Santos2, Edgar A Flores-Reyes1
1Hospital Del Niño Dr. Federico Gómez Santos, Saltillo, Coah. México.
Background:
In Mexico, 70.6% of serotypes causing invasive pneumococcal disease were covered since the application of the PCV13 vaccine in children under 5 years of age. After several years of immunization, cases of disease caused by the serotypes included in the vaccine have decreased. However, a replacement due to serotypes not included in the vaccine has been observed.
Case Report:
Three cases of pediatric patients who developed invasive disease due to serotypes not included in PCV13 are described: one with meningitis and bacteremia (serotype 15C), and two with pneumonia, of which one complicated with effusion (serotype 35B). Patients were treated in a pediatric hospital in Saltillo, Coahuila, from 2015 to 2018.
Conclusions:
Three serious cases due to serotypes of Streptococcus pneumoniae not included in PCV13 were reported in a single pediatric hospital in a northern state of Mexico. This phenomenon is taking place nationwide and worldwide an increase of cases of invasive disease due to pneumococcal serotypes not included in the vaccine currently used.
Insights
The pneumococcal conjugate vaccine PCV13 reduced disease cases in Mexican children. However, invasive pneumococcal disease is increasing due to serotypes not covered by the PCV13 vaccine.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Microbiology
Background:
- The 13-valent pneumococcal conjugate vaccine (PCV13) was implemented in Mexico for children under 5.
- PCV13 effectively reduced invasive pneumococcal disease (IPD) caused by vaccine-included serotypes.
- A concerning trend of serotype replacement has been observed following widespread PCV13 use.
Observation:
- This report details three pediatric cases of IPD in Saltillo, Coahuila, between 2015 and 2018.
- Patients presented with meningitis, bacteremia, and pneumonia caused by Streptococcus pneumoniae serotypes not included in PCV13 (15C and 35B).
- One case of pneumonia complicated with effusion.
Findings:
- Invasive pneumococcal disease caused by non-PCV13 serotypes is emerging in pediatric populations.
- Serotype 15C was associated with meningitis and bacteremia.
- Serotype 35B was linked to pneumonia, including a complicated effusion case.
Implications:
- The findings highlight the need for ongoing surveillance of pneumococcal serotypes.
- Current vaccination strategies may require updates to address emerging non-vaccine serotypes.
- This phenomenon of serotype replacement is a global concern impacting vaccine efficacy and public health strategies.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

